Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (1y) (2010 - 2018)
Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (1y) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | 15.81% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -130.26% |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | 37.82% |
| 8 | Neurocrine Biosciences | 17.73 Bn | 16.42 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 100.17% |
| Dec 31, 2017 | 110.32% |
| Sep 30, 2017 | -23.06% |
| Jun 30, 2017 | 262.38% |
| Mar 31, 2017 | -2,155.99% |
| Dec 31, 2016 | -771.18% |
| Sep 30, 2016 | -11.82% |
| Jun 30, 2016 | 79.08% |
| Mar 31, 2016 | 2.78% |
| Dec 31, 2015 | 13.25% |
| Sep 30, 2015 | 28.18% |
| Jun 30, 2015 | -36.74% |
| Mar 31, 2015 | -42.63% |
| Dec 31, 2014 | -65.93% |
| Sep 30, 2014 | -80.15% |
| Jun 30, 2014 | -15.77% |
| Mar 31, 2014 | 28.95% |
| Dec 31, 2013 | 221.15% |
| Sep 30, 2013 | 312.05% |
| Jun 30, 2013 | 67.97% |